Raphael Landovitz

17PUBLICATIONS
95CO-AUTHORS
Behavioural epidemiologyPreventative health careMultimorbidityInformation systems user experience design and developmentMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 27, 2026
Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083.

|Apr 16, 2026
Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review and meta-analysis.

|Mar 26, 2026
Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve.

Christopher J Graber, Raphael J Landovitz, Westyn Branch-Elliman

|Mar 14, 2026
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.

Raphael J Landovitz, Yvett Pinedo, Federico Hinestrosa

|Jan 21, 2026
Emergence of a novel genotype of extensively drug-resistant Shigella sonnei carrying blaDHA-1 in diverse patient populations, Los Angeles, 2024-2025.

Shekina Gonzalez-Ferrer, Bennett Shaw, Lilian Fung

|Nov 08, 2025
Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083.

Brett Hanscom, Mark A Marzinke, Xinnong Li

Pageof 3

Frequent Collaborators

4 joint publications

Brett Hanscom

3 joint publications

Beatriz Grinsztejn

3 joint publications

Mark A Marzinke

3 joint publications

Craig W Hendrix